Skip to main content
OpenTrials
Completed

NCT Number: NCT01647646

Real Life Effectiveness in Patients With Not Optimally Controlled Asthma

In real life, the investigators will be using different strategies including SMART therapy or other ICS/LABA (medium and high dose) therapy and measure the efficacy for asthma control.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Asthma Bronchial Diseases Hypersensitivity Hypersensitivity, Immediate Immune System Diseases Lung Diseases Lung Diseases, Obstructive Respiratory Hypersensitivity Respiratory Tract Diseases

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

About this study

  • All not-well controlled asthma patients would include the study.
  • We will compare three ways of asthma control including SMART, fixed doses with regular doses and fixed doses with higher doses
  • We will evaluate the efficacy/safety for these not-well controlled patients.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • asthma not well control

Exclusion criteria

  • COPD

Treatment and study plan

Seretide

Drug

Using Symbicort and Seretide for asthma control measurements Compared with efficacy and safety

Other names: Symbicort compared with Seretide

Primary outcomes

  1. the percentage of asthma total and well control

    Time frame: one year

    F/U clinical asthma control status and percentage of Acute exacerbation

Secondary outcomes

  1. percentage of asthma acute exacerbation

    Time frame: one year

Sponsors and collaborators

Lead sponsor

Far Eastern Memorial Hospital

Other

Registry information

Official study title

Real Life Effectiveness in Patients With Not Optimally Controlled Asthma: Symbicort SMART, or Other ICS/LABA With as Needed SABA

Important dates

Study start
2009
Primary completion
2011
Study completion
2012
First posted
Jul 23, 2012
Registry last updated
Jul 24, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.